Alvita Pharma Private Limited

Alvita Pharma Private Limited (APPL) is a pharmaceutical company based in Mumbai, India. With a strong presence in branded generic business across Africa, South East Asia, and Eastern Europe, APPL markets over 600 products in various therapeutic segments. The company boasts advanced research facilities for formulation and product development in Mumbai and Vadodara, and is known for launching first-to-market products in different countries to provide access to high-quality and affordable medicines. APPL's new manufacturing unit in Vadodara is expected to obtain European Union approval by March, 2023, and its joint venture has enhanced API unit capability to improve cost efficiency. The company is also focused on expanding its India business through the launch of innovative molecules and formulations, with active work in business development and licensing underway. APPL's dedication to core values such as reliability, trustworthiness, adaptability, accountability, and quality consciousness has resulted in a loyal customer base, supported by the principle of "Once a customer, Always our customer." In its efforts to add value for customers, APPL continually expands its product registration database to address unmet patient needs in the countries where it operates. With a founding year of 2010, the company operates in the health and wellness, manufacturing, pharmaceutical, and marketing sectors. While specific information regarding the company's headquarters and its last investment are not available at the moment, APPL's commitment to quality and expansion presents an interesting opportunity for potential investors in the healthcare and pharmaceutical industries.